Literature DB >> 30323034

Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

E Glampedakis1, A T Coste2, M Aruanno2, D Bachmann2, E Delarze2, V Erard3, F Lamoth4,2.   

Abstract

Invasive fungal infections due to Aspergillus calidoustus with decreased azole susceptibility are emerging in the setting of azole prophylaxis and are associated with poor outcomes. We assessed the in vitro activity of antifungal drugs used alone or in combinations against A. calidoustus and found a synergistic effect between voriconazole and terbinafine at concentrations within the therapeutic range. An invertebrate Galleria mellonella model of A. calidoustus infection tended to support the potential benefit of this combination.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus ustuszzm321990; Galleria mellonellazzm321990; Ustizzm321990; amphotericin B; invasive fungal infections; synergism; terbinafine; voriconazole

Mesh：

Substances：

Year:  2018        PMID： 30323034      PMCID： PMC6256776          DOI： 10.1128/AAC.01137-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.

Authors:  N S Ryder; I Leitner
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

Authors:  Frederic Lamoth; Shimin J Chung; Lauro Damonti; Barbara D Alexander
Journal:  Clin Infect Dis       Date:  2017-06-01       Impact factor: 9.079

3.  Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.

Authors:  Adrian Egli; Jeff Fuller; Atul Humar; Dale Lien; Justin Weinkauf; Roland Nador; Ali Kapasi; Deepali Kumar
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

4.  Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Authors:  A Espinel-Ingroff; D J Diekema; A Fothergill; E Johnson; T Pelaez; M A Pfaller; M G Rinaldi; E Canton; J Turnidge
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

5.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

7.  Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.

Authors:  Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar; Elias K Manavathu; Sanjay G Revankar
Journal:  Diagn Microbiol Infect Dis       Date:  2008-10-07       Impact factor: 2.803

8.  Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.

Authors:  Wendy Kloezen; Florianne Parel; Roger Brüggemann; Khalid Asouit; Marilyn Helvert-van Poppel; Ahmed Fahal; Johan Mouton; Wendy van de Sande
Journal:  Med Mycol       Date:  2018-06-01       Impact factor: 4.076

9.  New taxa in Aspergillus section Usti.

Authors:  R A Samson; J Varga; M Meijer; J C Frisvad
Journal:  Stud Mycol       Date:  2011-06-30       Impact factor: 16.097

10.  Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models.

Authors:  Sara Amorim-Vaz; Eric Delarze; Françoise Ischer; Dominique Sanglard; Alix T Coste
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640
View more
  6 in total

1.  Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.

Authors:  Maria A Mendoza; Anthony Anderson; Michele I Morris; Lazaros Lekakis; Jacques Simkins; Clara E Prado; Octavio V Martinez; Krishna V Komanduri; Jose F Camargo
Journal:  Mycopathologia       Date:  2020-01-10       Impact factor: 2.574

2.  Case Commentary: Long-Term Fosmanogepix Use in a Transplant Recipient with Disseminated Aspergillosis Caused by Azole-Resistant Aspergillus calidoustus.

Authors:  Ahnika Kline; Michail S Lionakis
Journal:  Antimicrob Agents Chemother       Date:  2022-01-24       Impact factor: 5.938

Review 3.  Galleria mellonella for the Evaluation of Antifungal Efficacy against Medically Important Fungi, a Narrative Review.

Authors:  Sana Jemel; Jacques Guillot; Kalthoum Kallel; Françoise Botterel; Eric Dannaoui
Journal:  Microorganisms       Date:  2020-03-11

Review 4.  Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.

Authors:  Frederic Lamoth; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2020-12-30

5.  Pharmacokinetic profile of sarcin and thionin from Aspergillus giganteus and in vitro validation against human fungal pathogen.

Authors:  Ramya Ravindhiran; Ramya Krishnamurthy; Karthiga Sivarajan; Jothi Nayaki Sekar; Kumarappan Chidambaram; Ali M Alqahtani; Kavitha Dhandapani
Journal:  Biosci Rep       Date:  2022-09-30       Impact factor: 3.976

Review 6.  Clinical Relevance and Characteristics of Aspergillus calidoustus and Other Aspergillus Species of Section Usti.

Authors:  Emmanouil Glampedakis; Véronique Erard; Frederic Lamoth
Journal:  J Fungi (Basel)       Date:  2020-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.